Survival analysis of intraoperative blood salvage for patients with malignancy disease: A PRISMA-compliant systematic review and meta-analysis

Medicine (United States)

Volumn 98, Issue 27, 2019, Pages

  Wu, Wei Wei ^a   Zhang, Wei Yi ^a   Zhang, Wei Han ^a   Yang, Lei ^a   Deng, Xiao Qian ^a   Ou, Meng Chan ^a   Yang, Yao Xin ^a   Liu, Hai Bei ^a   Zhu, Tao ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Allogenic blood transfusion; Intraoperative blood salvage; Recurrence rate; Survival outcomes; Tumor

Indexed keywords

BLOOD AUTOTRANSFUSION; BLOOD SALVAGE; DISEASE FREE SURVIVAL; ETIOLOGY; FEMALE; HUMAN; MALE; META ANALYSIS; NEOPLASM; RETROSPECTIVE STUDY; SURVIVAL ANALYSIS; TUMOR RECURRENCE;

BLOOD TRANSFUSION, AUTOLOGOUS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; OPERATIVE BLOOD SALVAGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 85069269715     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000016040     Document Type: Review

References (46)

1. Foltys D, Zimmermann T, Heise M, et al. Liver transplantation for hepatocellular carcinoma-is there a risk of recurrence caused by intraoperative blood salvage autotransfusion? Eur Surg Res 2011;47:182-7.
2. Kim JM, Kim GS, Joh JW, et al. Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter. Transpl Int 2013;26:84-9.
3. Brzica SMJr, Pineda AA, Taswell HF. Autologous blood transfusion. Mayo Clin Proc 1976;51:723-37.
4. Basran S, Frumento RJ, Cohen A, et al. The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery. Anesth Analg 2006;103:15-20. table of contents.
5. Yaw PB, Sentany M, Link WJ, et al. Tumor cells carried through autotransfusion. Contraindication to intraoperative blood recovery? JAMA 1975;231:490-1.
6. Autologous blood transfusionsCouncil on scientific affairs. JAMA 1986;256:2378-80.
7. Kumar N, Lam R, Zaw AS, et al. Flow cytometric evaluation of the safety of intraoperative salvaged blood filtered with leucocyte depletion filter in spine tumour surgery. Ann Surg Oncol 2014;21:4330-5.
8. Whitlock EL, Kim H, Auerbach AD. Harms associated with single unit perioperative transfusion: retrospective population based analysis. BMJ 2015;350:h3037.
9. Vamvakas EC. Possible mechanisms of allogeneic blood transfusionassociated postoperative infection. Transfus Med Rev 2002;16:144-60.
10. Ueda J, Ikota N, Hanaki A, et al. Synthesis of new oligopeptides and their scavenging abilities against active oxygen species. Biochem Mol Biol Int 1994;33:1041-8.
11. Flohe S, Kobbe P, Nast-Kolb D. Immunological reactions secondary to blood transfusion. Injury 2007;38:1405-8.
12. Goubran H, Sheridan D, Radosevic J, et al. Transfusion-related immunomodulation and cancer. Transfus Apher Sci 2017;56:336-40.
13. Silliman CC, McLaughlin NJ. Transfusion-related acute lung injury. Blood Rev 2006;20:139-59.
14. Sachs UJ. The pathogenesis of transfusion-related acute lung injury and how to avoid this serious adverse reaction of transfusion. Transfus Apher Sci 2007;37:273-82.
15. Asmuth DM, Kalish LA, Laycock ME, et al. Absence of HBV and HCV, HTLV-I and -II, and human herpes virus-8 activation after allogeneic RBC transfusion in patients with advanced HIV-1 infection. Transfusion 2003;43:451-8.
16. Goodnough LT, Brecher ME, Kanter MH, et al. Transfusion medicine. First of two parts-blood transfusion. N Engl J Med 1999;340:438-47.
17. Ubee S, Kumar M, Athmanathan N, et al. Intraoperative red blood cell salvage and autologous transfusion during open radical retropubic prostatectomy: a cost-benefit analysis. Ann R Coll Surg Engl 2011;93:157-61.
18. Connor JP, Morris PC, Alagoz T, et al. Intraoperative autologous blood collection and autotransfusion in the surgical management of early cancers of the uterine cervix. Obstet Gynecol 1995;86:373-8.
19. Williamson KR, Taswell HF. Intraoperative blood salvage: a review. Transfusion 1991;31:662-75.
20. Zaw AS, Bangalore Kantharajanna S, Kumar N. Is autologous salvaged blood a viable option for patient blood management in oncologic surgery? Transfus Med Rev 2017;31:56-61.
21. Moher D, Liberati A, Tetzlaff J, et al. Group PPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
22. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603-5.
23. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13.
24. Mirhashemi R, Ganjei-Azar P, Nadji M, et al. Papillary squamous cell carcinoma of the uterine cervix: an immunophenotypic appraisal of 12 cases. Gynecol Oncol 2003;90:657-61.
25. Stoffel JT, Topjian L, Libertino JA. Analysis of peripheral blood for prostate cells after autologous transfusion given during radical prostatectomy. BJU Int 2005;96:313-5.
26. Ubee SS, Manikandan R, Gudimetla AR, et al. Cost benefits of intraoperative cell salvage in radical cystectomy. Indian J Urol 2010;26:196-9.
27. Bower MR, Ellis SF, Scoggins CR, et al. Phase II comparison study of intraoperative autotransfusion for major oncologic procedures. Ann Surg Oncol 2011;18:166-73.
28. Lyon TD, Ferroni MC, Turner RM2nd, et al. Short-term outcomes of intraoperative cell saver transfusion during open partial nephrectomy. Urology 2015;86:1153-8.
29. Elmalky M, Yasin N, Rodrigues-Pinto R, et al. The safety, efficacy, and cost-effectiveness of intraoperative cell salvage in metastatic spine tumor surgery. Spine J 2017;17:977-82.
30. Nieder AM, Carmack AJ, Sved PD, et al. Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate. Urology 2005;65:730-4.
31. Nieder AM, Manoharan M, Yang Y, et al. Intraoperative cell salvage during radical cystectomy does not affect long-term survival. Urology 2007;69:881-4.
32. Engle DB, Connor JP, Morris PC, et al. Intraoperative autologous blood transfusion use during radical hysterectomy for cervical cancer: longterm follow-up of a prospective trial. Arch Gynecol Obstet 2012;286:717-21.
33. Gorin MA, Eldefrawy A, Manoharan M, et al. Oncologic outcomes following radical prostatectomy with intraoperative cell salvage. World J Urol 2012;30:379-83.
34. Akbulut S, Kayaalp C, Yilmaz M, et al. Effect of autotransfusion system on tumor recurrence and survival in hepatocellular carcinoma patients. World J Gastroenterol 2013;19:1625-31.
35. Araujo RL, Pantanali CA, Haddad L, et al. Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence? World J Gastrointest Surg 2016;8: 161-8.
36. Han S, Kim G, Ko JS, et al. Safety of the use of blood salvage and autotransfusion during liver transplantation for hepatocellular carcinoma. Ann Surg 2016;264:339-43.
37. Kim YK, Chin JH, Kang SJ, et al. Association between central venous pressure and blood loss during hepatic resection in 984 living donors. Acta Anaesthesiol Scand 2009;53:601-6.
38. Shu Y, Zhang W, Hou Q, et al. Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer. Nat Commun 2018;9:2447.
39. Tohme S, Simmons RL, Tsung A. Surgery for cancer: a trigger for metastases. Cancer Res 2017;77:1548-52.
40. Lee BM, Cata JP. Impact of anesthesia on cancer recurrence. Rev Esp Anestesiol Reanim 2015;62:570-5.
41. Cata JP, Wang H, Gottumukkala V, et al. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth 2013;110:690-701.
42. Chung M, Steinmetz OK, Gordon PH. Perioperative blood transfusion and outcome after resection for colorectal carcinoma. Br J Surg 1993;80:427-32.
43. Yao HS, Wang Q, Wang WJ, et al. Intraoperative allogeneic red blood cell transfusion in ampullary cancer outcome after curative pancreatoduodenectomy: a clinical study and meta-analysis. World J Surg 2008;32:2038-46.
44. Gwak MS, Lee KW, Kim SY, et al. Can a leukocyte depletion filter (LDF) reduce the risk of reintroduction of hepatocellular carcinoma cells? Liver Transpl 2005;11:331-5.
45. Ciepluch B, Wilson-Robles H, Levine G, et al. Removal of hemangiosarcoma cells from canine blood with a cell salvage system and leukocyte reduction filter. Vet Surg 2018;47:293-301.
46. Kumar N, Ahmed Q, Lee VK, et al. Can there be a place for intraoperative salvaged blood in spine tumor surgery? Ann Surg Oncol 2014;21:2436-43.